FIGURE

Figure 3

ID
ZDB-FIG-210310-7
Publication
Iscan et al., 2021 - TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation
Other Figures
All Figure Page
Back to All Figure Page
Figure 3

TAp73β down-regulates cell proliferation by increasing the proportion of cells at G0/G1 phase at the expense of S and G2/M phase cells. Gene set enrichment analyses showing the repression of (A) Myc-target genes, (B) E2F target genes, (C) genes involved in G2/M cell cycle progression, and (D) mitotic spindle associated genes. (E) TAp73β causes moderate inhibition of cell cyle progression by increasing the relative number of cells at G0/G1 phase. Hep3BTAp73β cells were treated with doxycycline (1 µg/mL) for 72 h, and cell cycle distribution was evaluated by using flow cytometric DNA content analysis. (F) TAp73β decreases cell proliferation by 40%, but does not stop cell growth. Hep3BTAp73β cells were exposed to doxycycline (1 µg/mL) for 0 h, 24 h, 48 h and 72 h. At the end of the indicated times, cell proliferation was measured by the SRB method. Columns and error bars indicate ± SD from triplicate experiments. ** p < 0.001 and *** p < 0.0001 for significant differences between cells treated and not treated with doxycycline.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers